Skip to main content

By: University of Cincinnati Cancer Center

Spring Pilot Project Awardees - May 2024

The University of Cincinnati Cancer Center Pilot Project Award Program is dedicated to advancing cancer research by providing pilot funding to our faculty investigators. This Spring 2024 cycle we celebrate 8 investigators whose pilot research received funding.

  • Tags:
  • Pilot Grants,
Full story About: Spring Pilot Project Awardees - May 2024

By: University of Cincinnati Cancer Center

Survivorship Grant Awardees Spotlight - April 2024

  • Tags:
  • Survivorship Grant,
Full story About: Survivorship Grant Awardees Spotlight - April 2024

By: University of Cincinnati Cancer Center

Tammy Mentzel, MPH Named Executive Director for Center Administration

Tammy Mentzel, MPH, has been named Executive Director for Center Administration and Associate Director for Administration at the University of Cincinnati Cancer Center.

  • Tags:
  • Cancer Center,
  • Cancer Leadership,
Full story About: Tammy Mentzel, MPH Named Executive Director for Center Administration

By: University of Cincinnati Cancer Center

A Spotlight on Pancreatic Cancer at the Waters Laboratory

Andrew Waters, PhD, a basic scientist at the University of Cincinnati Cancer Center and assistant professor within the Division of Surgical Oncology and the Department of Cancer Biology at UC, runs a research lab focusing on the molecular consequences and resistance mechanisms to KRAS inhibitors.

  • Tags:
  • Cancer Center,
  • Clinical Trials,
  • Pancreatic Cancer,
Full story About: A Spotlight on Pancreatic Cancer at the Waters Laboratory

By: University of Cincinnati Cancer Center

Clinical Trial Highlight: Phase 2 Study Evaluates LN-145 in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)

The University of Cincinnati Cancer Center Clinical Trials Office recently opened a trial to study the efficacy of LN-145 on patients with advanced lung cancer. This treatment involves the infusion of patients’ own immune cells, tumor-infiltrating lymphocytes (TIL), to evaluate the efficacy of LN-145 as determined by objective response rates (ORR).

  • Tags:
  • Cancer Research,
  • Clinical Trial,
Full story About: Clinical Trial Highlight: Phase 2 Study Evaluates LN-145 in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)

By: University of Cincinnati Cancer Center

10th Annual Charge Against Cancer Symposium Tackles AI

How will the explosion of AI impact cancer research and care? Last month, the University of Cincinnati Cancer Center held the tenth annual Charge Against Cancer Symposium on “Leveraging Artificial Intelligence and Data Sciences to Conquer Cancer” to tackle this topic.

  • Tags:
  • Cancer Center Event,
  • Cancer Research,
  • Professional Development,
Full story About: 10th Annual Charge Against Cancer Symposium Tackles AI

By: University of Cincinnati Cancer Center

Clinical Trial Highlight: New Beat AML Sub-Study Examines the Efficacy of Using a Lower-Dose of Common Treatment in Patients with Newly Diagnosed AML

The University of Cincinnati Cancer Center Clinical Trials Office recently opened a trial to compare a lower-than-standard dosage of a widely used treatment in newly diagnosed acute myeloid leukemia (AML) patients. This clinical trial is designed to evaluate the efficacy this dosage and treatment schedule of Venetoclax plus Azacitidine may have for newly diagnosed AML patients.

  • Tags:
  • Cancer Research,
  • Clinical Trial,
Full story About: Clinical Trial Highlight: New Beat AML Sub-Study Examines the Efficacy of Using a Lower-Dose of Common Treatment in Patients with Newly Diagnosed AML

By: University of Cincinnati Cancer Center

Tammy Holm, MD, PhD Awarded ThyCa Award

  • Tags:
  • awards,
  • Endocrine,
  • Thyroid Cancer,
Full story About: Tammy Holm, MD, PhD Awarded ThyCa Award

By: University of Cincinnati Cancer Center

Survivorship Grant Awardees Spotlight - May 2023

  • Tags:
  • Cancer Center,
  • Grants,
  • Survivorship,
Full story About: Survivorship Grant Awardees Spotlight - May 2023

By: University of Cincinnati Cancer Center

A Spotlight on Head & Neck Cancers at the Takiar & Wise-Draper Laboratory

  • Tags:
  • Cancer Center,
  • Clinical Trials,
  • Head & Neck Cancer,
Full story About: A Spotlight on Head & Neck Cancers at the Takiar & Wise-Draper Laboratory

By: Karen Bankston, PhD, MSN

Cancer Care in the Black Community

Black people have the highest death rate and shortest survival of any racial/ethnic group in the United States for most cancers. An underlying source of health disparities among people of color is structural racism, which is defined as discrimination perpetuated through interconnected institutions and reinforced through culture, history, ideology, and sanctioned practices.

  • Tags:
  • Community Outreach,
  • DEI,
Full story About: Cancer Care in the Black Community

Contact Us

University of Cincinnati
Cancer Center

231 Albert Sabin Way, Suite 2005
Cincinnati, OH 45267
Phone: 513-558-2177
Fax: 513-558-2666